Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 107 publications.

Marcano Belisario JS, Bruggeling MN, Gunn LH, Brusamento S, Car J. Interventions for recruiting smokers into cessation programmes. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD009187. doi: 10.1002/14651858.CD009187.pub2

See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiol. 2012 Dec;19(6):407-13.

Parikh R, Taychakhoonavudh S, Ganduglia C, Franzini L. Geographic variation in cesarean section rates across hospital referral regions in Texas: a 2008-2010 analysis. Poster presented at the 13th Kelsey Research Foundation Health Services and Outcomes Research Annual Conference; December 2012. Houston, TX.

Karanth S, Lairson DR, Fernandez ME, Savas LS, Vernon SW, Fernandez-Espada N. Development cost of print and tailored interactive multimedia interventions to promote HPV vaccination. Poster presented at the 28th Annual International Papillomavirus Conference (IPV) & Clinical Workshops; December 2012. San Juan, Puerto Rico.

Goyal RK, Rajan SS, Essien EJ, Sansgiry SS. Effectiveness of FDA's new over-the-counter acetaminophen label warning requirements in improving consumer risk perception of liver damage. J Clin Pharm Ther. 2012 Dec;37(6):681-5. doi: 10.1111/j.1365-2710.2012.01371.x.

Davis KL, Price GL, Karve SJ, Pohl G, Walgren RA. Comorbidity burden in elderly persons with non-cml myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):1734. doi: 10.1182/blood.V120.21.1734.1734

Karve SJ, Price GL, Davis KL, Pohl G, Walgren RA. Health care utilization and associated costs in elderly persons with myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):4273. doi: 10.1182/blood.V120.21.4273.4273

Price GL, Davis KL, Karve SJ, Pohl G, Walgren RA. Survival patterns in elderly patients with myeloproliferative neoplasms: real-world evidence from a United States Medicare population. Poster presented at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2012. Atlanta, GA. [abstract] Blood. 2012 Nov 16; 120(21):428. doi: 10.1182/blood.V120.21.428.428

Candrilli S, Davis KL, Yen L. Characteristics of diverticulitis-related emergency department visits in the United States. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A328.

Stull DE, Houghton KF, Petrillo J. Rethinking analysis of outcome measures for demonstrating value of pharmaceutical products: implications for study design, personalized medicine, and comparative effectiveness research. Presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany.

Mitra D, Whiteley J, Iyer S, Candrilli S, Kaye JA. Treatment and response patterns in chronic myeloid leukemia: evidence from a retrospective study in Canada, Australia, and South Korea. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A413. doi: 10.1016/j.jval.2012.08.1217

Bailey DB, Raspa M, Bishop E, Mitra D, Wheeler A, Sacco P. Health and economic consequences of Fragile X syndrome for caregivers. J Dev Behav Pediatr. 2012 Nov 1;33(9):705-12.

Davis KL, Mitra D, Yen L. Clinical characteristics, treatment patterns, and resource utilization in a real-world European population with diverticulitis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A535-6.

Mauskopf J, Beach W, McIntyre L, Bhattacharyya S, Higgins L, Mordin M, Copley-Merriman K. Evidence-based medicine: a case study of its application to innovative surgical procedures in the United Kingdom. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 7, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A408.

Cohen C, Davis KL, Meyers JL. Association of partial adherence (PA) to antiretroviral therapy with hospitalizations and healthcare costs in an HIV population. Poster presented at the 11th International Congress on Drug Therapy in HIV Infection; November 2012.

Helbert M, Pang F, Alvarez-Reyes M, Pearson IV, Wolowacz S, Diwakar L. A cost-effectiveness comparison of icatibant and c1-esterase inhibitor concentrate for the symptomatic treatment of acute attacks of types i and ii hereditary angioedema in the UK setting. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 13, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A513.

Hicks K, Earnshaw S, McDade C, Shaw JW, Cifaldi MA. Benefit-risk analysis of adalimumab and alternative treatments for moderate to severe rheumatoid arthritis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 13, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A439-40.

Wheeler SB, Kohler RE, Goyal RK. Guideline-concordant surveillance and follow-up care among low-income patients with breast cancer: the role of primary care medical homes. Poster presented at the Quality Care Symposium of the American Society of Clinical Oncology; November 2012.

Mersey J, Wei W, Meyers J, Wang CC, Dalal MR, Bromberger LA, Levin P. Real-world treatment patterns and outcomes when initiating once-daily injectable pen therapy with insulin glargine or liraglutide - an electronic medical records study. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A494. doi: 10.1016/j.jval.2012.08.1648

Karve SJ, Panish JM, Dirani RG, Candrilli SD. Health care utilization and costs among Medicaid-enrolled patients with schizophrenia experiencing multiple psychiatric relapses. Health Outcomes Res Med. 2012 Nov 1;3(4):e183-94.

Pearson IV, Wolowacz SE, Irving AH, Brockbank JA, Chubb B, Gundgaard J, Briggs A, Davies M. A systematic review of recent data describing the risk of complications in type 1 diabetes mellitus patients. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A496-7.

Pletcher MJ, Earnshaw SR, Auer R, Phillips KA, Greenland P, Pignone M. Using the coronary calcium score to guide statin therapy: a cost-effectiveness analysis. Poster presented at the Scientific Sessions of the American Heart Association; November 2012.

Auer R, Kazi DS, Earnshaw SR, Pignone M, Pletcher MJ. Horizon and perspective: critical choices in estimating cost-effectiveness of cardiovascular prevention. Poster presented at the Scientific Sessions of the American Heart Association; November 2012.

Davis KL, Tangiral K, Meyers JL, Wei W. Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Mauskopf J, Brodan A, Martin S, Smets E. Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA. Pharmacoeconomics. 2012 Oct;28 Suppl 1:83-105. doi: 10.2165/11587470-000000000-00000

Meyers J, Candrilli S, Allen R, Manjunath R, Calloway M. Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists. Manag Care. 2012 Oct 1;21(10):44-51.

Karve S, Candrilli S, Kappelman MD, Tolleson-Rinehart S, Tennis P, Andrews E. Healthcare utilization and comorbidity burden among children and young adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease. J Pediatr. 2012 Oct 1;161(4):662-670.e. doi: 10.1016/j.jpeds.2012.03.045

Karanth S, Lairson DR, Ball Ricks KA, Fernández ME. Intervention costs of the 2-1-1 call center-based cancer control navigator program to increase breast, cervical and colorectal cancer screening among underserved texans. Poster presented at the Cancer Prevention and Control Research Network; October 2012. Houston, TX.

Dalal M, Ling Z, Davis KL, Meyers JL, Digenio A. Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analog therapy. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Domino M, Wells R, Cilenti D, Kum H-C, Goyal RK, Whitmire T, Summers R. How sensitive are local health departments to funding cuts? An application to maternal care services. Poster presented at the American Society of Health Economists; October 2012. Minneapolis, MN.

Digenio A, Ling Z, Davis KL, Meyers JL, Dalal M. Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus liraglutide or insulin glargine plus exenatide. Poster presented at the 48th Annual Meeting of the European Association for the Study of Diabetes; October 2012.

Mehta H, Patel J, Parikh RC, Abughosh S. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct;15(5):287-92.

Davis AE, Mehrotra S, Friedewald J. Improving utilization and outcomes of high kidney donor profile index kidney transplants. Poster presented at the Annual Meeting ofthe Institute for Operations Research and Management Science; October 2012. Previously presented at the 2010 American Transplant Congress.

Rubin DT, Mody R, Wang E, Davis KL. Assessment of therapy changes and drug discontinuation among crohn's disease patients using health claims data. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2012.

Earnshaw SR. Research in a non-academic setting. Presented at the UNC Fall Seminar in Pharmaceutical Outcomes and Policy; September 26, 2012. Durham, NC.

Mitra D, Hodgkins P, Yen L, Davis KL, Cohen RD. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol. 2012 Sep 1;12(Sept):132.

Fleming AD, Philip S, Goatman KA, Sharp PF, Olson JA. Automated clarity assessment of retinal images using regionally based structural and statistical measures. Med Eng Phys. 2012 Sep 1;34(7):849-59. doi: 10.1016/j.medengphy.2011.09.027

Cilenti D, Wells R, Kum HC, Domino M, Goyal RK, Hillemeier M. How NC maternal and child health services and outcomes changed during a period of revenue cuts. Poster presented at the NC Public Health Association Conference; September 2012.

Launois R, Le Moine JG, Lozano FS, Mansilha A. Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure. Qual Life Res. 2012 Aug;21(6):1051-8. doi: 10.1007/s11136-011-0008-3

Ara R, Basarir H, Ward SE. Principles of health economic evaluations of lipid-lowering strategies. Curr Opin Lipidology. 2012 Aug;23(4):271-81. doi: 10.1097/MOL.0b013e32835423d9

Ferguson JE3rd, Goyal RK, Raynor MC, Nielsen ME, Pruthi RS, Brown PM, Wallen EM. Cost analysis of robot-assisted laparoscopic versus hand-assisted laparoscopic partial nephrectomy. J Endourol. 2012 Aug;26(8):1030-7.

Mauskopf JA, Candrilli SD, Chevrou-Severac H, Ochoa JB. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012 Jul 1;10:136.

Armbruster B, Lucas AM. Effectiveness of a no-sex or safe-sex month in reducing HIV transmission. Bull World Health Organ. 2012 Jul;90(7):477-556. doi: 10.2471/BLT.11.088641

Earnshaw SR, McDade C, Chapman AM, Jackson D, Schwamm L. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom. Clin Ther. 2012 Jul 1;34(7):1544-58.

Hartley L, Girling A, Bowater R, Lilford R. Inter-continental differences in the clinical effectiveness of medical interventions: a study using panoramic meta-analysis. Presented at the Department of Health Sciences Seminar at the University of Warwick; June 19, 2012. Coventry, United Kingdom.

Wolowacz SE, Pearson IV, Roskell NS, Shannon PR, Chubb B, Gundgaard J. Development and validation of a cost-utility model for Type 1 diabetes mellitus. Presented at the Mount Hood Six Challenge; June 7, 2012.

Davis KL, Yen L, Loftus E, Hodgkins P. Pre-to-postdiagnosis increase in utilization and costs of chronic-use medications and other medical resources in managed care enrollees with diverticulitis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 6, 2012.

Launois R, Le Moine JG, Huynh MT. Mixed treatment comparison, cost-effectiveness and budget impact analysis in the treatment of rheumatoid arthritis after failure of DMARD therapy: a comprehensive decision analytical modelling. Poster presented at the International Society for Pharmacoeconomics and Outcome Research 17th Annual International Meeting; June 2, 2012. Washington, DC.

Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.

Davis KL, Yen L, Loftus EV, Hodgkins P. Pre- to post-diagnosis increase in utilization and costs of chronic-use medications and other medical resources in managed care enrollees with diverticulitis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 1, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A138.